OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In Silico Strategies for Designing of Peptide Inhibitors of Oncogenic K-Ras G12V Mutant: Inhibiting Cancer Growth and Proliferation
Mehreen Ghufran, Haider Ali Khan, Mehran Ullah, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4884-4884
Open Access | Times Cited: 23

Showing 23 citing articles:

Targeting Peptides: The New Generation of Targeted Drug Delivery Systems
Biagio Todaro, Elisa Ottalagana, Stefano Luin, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1648-1648
Open Access | Times Cited: 32

Leveraging Marine Predators Algorithm with Deep Learning for Lung and Colon Cancer Diagnosis
Hanan Abdullah Mengash, Mohammad Alamgeer, Mashael Maashi, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1591-1591
Open Access | Times Cited: 29

RAS‐targeted cancer therapy: Advances in drugging specific mutations
Cen Liu, Danyang Ye, Hongliu Yang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 18

In silico mutagenesis-based designing of oncogenic SHP2 peptide to inhibit cancer progression
Muhammad Shahab, Shahin Shah Khan, Maryam Zulfat, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17

Structural insights, regulation, and recent advances of RAS inhibitors in the MAPK signaling cascade: a medicinal chemistry perspective
Vimal H. Prajapati, Ankit Kumar Singh, Adarsh Kumar, et al.
RSC Medicinal Chemistry (2025)
Closed Access

Phyto-fabrication of ultrafine nanoscale holmium oxide HT-Ho2O3 NPs and their biomedical potential
Hamza Elsayed Ahmed Mohamed, Ali Talha Khalil, Khaoula Hkiri, et al.
RSC Advances (2023) Vol. 13, Iss. 40, pp. 27912-27922
Open Access | Times Cited: 11

Evolution of computational techniques against various KRAS mutants in search for therapeutic drugs: a review article
Asif Mehmood, Mohammed Ageeli Hakami, Hanan A. Ogaly, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access

Unconventional strategy could be the future: From target to KRAS broad range treatment
Sara Fancelli, Giulia Petroni, Serena Pillozzi, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29739-e29739
Open Access | Times Cited: 3

Integrated Bioinformatics-Based Subtractive Genomics Approach to Decipher the Therapeutic Drug Target and Its Possible Intervention against Brucellosis
Kanwal Khan, Munirah Sulaiman Othman Alhar, Muhammad Abbas, et al.
Bioengineering (2022) Vol. 9, Iss. 11, pp. 633-633
Open Access | Times Cited: 13

Phytochemical analysis, radical scavenging and glioblastoma U87 cells toxicity studies of stem bark of buckthorn (Rhamnus pentapomica R. Parker)
Yaseen Ur Rehman, Arshad Iqbal, Gowhar Ali, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Phytochemicals-based β-amyloid cleaving enzyme-1 and MAO-B inhibitors for the treatment of Alzheimer’s disease: molecular simulations-based predictions
Mater H. Mahnashi, Muhammad Ayaz, Mehreen Ghufran, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-13
Closed Access | Times Cited: 4

Molecular screening of phytocompounds targeting the interface between influenza A NS1 and TRIM25 to enhance host immune responses
Muhammad Suleman, Abrar Mohammad Sayaf, Abbas Khan, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 7, pp. 102448-102448
Open Access | Times Cited: 1

In Silico Targeting of Fascin Protein for Cancer Therapy: Benchmarking, Virtual Screening and Molecular Dynamics Approaches
Heba H. A. Hassan, Muhammad I. Ismail, Mohammed A. S. Abourehab, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1296-1296
Open Access | Times Cited: 3

Immunoinformatic based designing of highly immunogenic multi-epitope subunit vaccines to stimulate an adaptive immune response against Junin virus
Mohammed Alissa, Abdullah Alghamdi, Suad A. Alghamdi, et al.
Molecular Diversity (2024)
Closed Access

Experimental Validation of MHC Class I and II Peptide-Based Potential Vaccine Candidates for Human Papilloma Virus Using Sprague-Dawly Models
Mehreen Ismail, Baogang Bai, Jinlei Guo, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1687-1687
Open Access | Times Cited: 1

Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer
Ignacio Alfaro, Margarita Vega, Carmen Romero, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1515-1515
Open Access

Silencing effects of mutant RAS signalling on transcriptomes
Christine Sers, Reinhold Schäfer
Advances in Biological Regulation (2022) Vol. 87, pp. 100936-100936
Closed Access

Page 1

Scroll to top